Recent advances in antithrombotic treatment for acute coronary syndromes.

about

Heparin: new life for an old drug.

P2860

Q40164066-5F6A4441-3910-4B42-9AD0-0E1F27646F6F

P2860

Recent advances in antithrombotic treatment for acute coronary syndromes.

Item

http://www.wikidata.org/entity/Q38216600

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Recent advances in antithrombotic treatment for acute coronary syndromes.

@en

type

Item

label

Recent advances in antithrombotic treatment for acute coronary syndromes.

@en

prefLabel

Recent advances in antithrombotic treatment for acute coronary syndromes.

@en

P1476

Recent advances in antithrombotic treatment for acute coronary syndromes

@en

P2093

Andrew Wragg

http://www.w3.org/2001/XMLSchema#string

James P Howard

http://www.w3.org/2001/XMLSchema#string

Sotiris Antoniou

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome

Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis

Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

Bivalirudin for patients with acute coronary syndromes

P304

507-521

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17512433.2014.923306

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniel A Jones

P577

2014-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262782000

http://www.w3.org/2001/XMLSchema#string

P698

24882677

http://www.w3.org/2001/XMLSchema#string

Recent advances in antithrombotic treatment for acute coronary syndromes.

about

P2860

P2860

Recent advances in antithrombotic treatment for acute coronary syndromes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698